Log In
Print this Print this

VAL-0620 (formerly 4s3-001)

  Manage Alerts
Collapse Summary General Information
Company Valerion Therapeutics LLC
DescriptionFusion protein of Valerion's 3E10, an equilibrative nucleoside transporter 2 (ENT2)-dependent cell-penetrant antibody, linked to myotubularin 1 (MTM1)
Molecular Target Myotubularin 1 (MTM1)
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Fusion protein
Latest Stage of DevelopmentPreclinical
Standard Indication Musculoskeletal (unspecified)
Indication DetailsTreat myotubular myopathy
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today